TY - JOUR
T1 - Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris
T2 - Comparison with monotherapy
AU - Hanet, Claude
AU - Pouleur, Hubert
AU - Harlow, Bryan J.
AU - Rousseau, Michel F.
PY - 1988/8
Y1 - 1988/8
N2 - To determine whether the association of nicardipine with propranolol had additive effects on myocardial metabolism, 16 patients with angina pectoris were studied invasively before and after 1 month of therapy with a combination of nicardipine and propranolol and compared to a group of 42 patients treated with nicardipine (n = 17) or propranolol (n = 25) alone. When data were compared at a fixed heart rate (atrial pacing), mean blood pressure was reduced with combined treatment from 96 ± 19 to 76 ± 13 mm Hg (p < 0.003). Myocardial oxygen uptake and coronary sinus flow decreased significantly from 20 ± 9 to 14 ± 6 ml/min (p < 0.015) and from 152 to 111 ml/min (p < 0.05), respectively. The arterio-coronary sinus difference in oxygen content also decreased (13.3 to 12.5 ml/dl; p < 0.0025), suggesting an improved balance be ween oxygen supply and demand. Such changes in coronary blood flow and myocardial oxygen uptake were not observed in the group of patients assigned to monotherapy. Lactate uptake rose and the abnormal glutamine production, which worsened with propranolol monotherapy, improved with nicardipine and propranolol (-2.0 to -1.4 μmol/min; p < 0.05 vs propranolol). The superiority of nicardipine and propranolol over propranolol monotherapy was maintained during a pacing stress test. Thus the combination of nicardipine with a beta blocker had greater oxygen-sparing effects and restored aerobic metabolism better than either drug alone, allowing optimal use of the coronary reserve.
AB - To determine whether the association of nicardipine with propranolol had additive effects on myocardial metabolism, 16 patients with angina pectoris were studied invasively before and after 1 month of therapy with a combination of nicardipine and propranolol and compared to a group of 42 patients treated with nicardipine (n = 17) or propranolol (n = 25) alone. When data were compared at a fixed heart rate (atrial pacing), mean blood pressure was reduced with combined treatment from 96 ± 19 to 76 ± 13 mm Hg (p < 0.003). Myocardial oxygen uptake and coronary sinus flow decreased significantly from 20 ± 9 to 14 ± 6 ml/min (p < 0.015) and from 152 to 111 ml/min (p < 0.05), respectively. The arterio-coronary sinus difference in oxygen content also decreased (13.3 to 12.5 ml/dl; p < 0.0025), suggesting an improved balance be ween oxygen supply and demand. Such changes in coronary blood flow and myocardial oxygen uptake were not observed in the group of patients assigned to monotherapy. Lactate uptake rose and the abnormal glutamine production, which worsened with propranolol monotherapy, improved with nicardipine and propranolol (-2.0 to -1.4 μmol/min; p < 0.05 vs propranolol). The superiority of nicardipine and propranolol over propranolol monotherapy was maintained during a pacing stress test. Thus the combination of nicardipine with a beta blocker had greater oxygen-sparing effects and restored aerobic metabolism better than either drug alone, allowing optimal use of the coronary reserve.
UR - http://www.scopus.com/inward/record.url?scp=0023766441&partnerID=8YFLogxK
U2 - 10.1016/0002-8703(88)90615-1
DO - 10.1016/0002-8703(88)90615-1
M3 - Article
C2 - 3041788
AN - SCOPUS:0023766441
SN - 0002-8703
VL - 116
SP - 431
EP - 439
JO - American Heart Journal
JF - American Heart Journal
IS - 2 PART 1
ER -